Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tapering Heart Failure Medication in Patients With Heart Failure With Recovered Ejection Fraction
NCT06724653Recruiting
- Sponsor
- Chungnam National University Hospital
- Start
- Mar 2025
- Primary completion
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of carvedilol in heart failure (HF) (3 arms), sponsored by Chungnam National University Hospital. Primary endpoint: Heart failure relapse at 18 months. Started Mar 2025; status: recruiting.
02
Drugs
carvedilol
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT06724653.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06724653.